BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• CollPlant Joins ReMDO’s Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs

  CollPlant announced that it is part of ReMDO’s advanced biomanufacturing initiative for the development of a universal BioInk with tunable properties for 3D bioprinting of tissues and organs.

  February 21, 2018

   · 

  4 min read
• Business

  United Therapeutics Corporation Reports 2017 Fourth Quarter And Annual Financial Results

  United Therapeutics Corporation announces their highest quarterly and annual net revenues ever.

  February 21, 2018

   · 

  25 min read
• Genetown

  Cerevance Kicks Off 2018 with Additional $10 Million of Infusions

  Cerevance, a drug discovery and development company focused on brain diseases, today announced that it has received an additional equity investment as well as a non-dilutive cash payment in the first six weeks of 2018 totaling more than $10 million.

  February 21, 2018

   · 

  2 min read
• Co-Diagnostics, Inc. Ships Product to India for Validation Study

  Co-Diagnostics, Inc. announced today a product shipment to India containing tests for tuberculosis to be sold as Research Use Only as well as others to be used in validation studies.

  February 21, 2018

   · 

  3 min read
• Biotech Beach

  Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia

  Evofem Biosciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Amphora® vaginal gel for the prevention of urogenital chlamydia in women.

  February 21, 2018

   · 

  5 min read
• BioCapital

  ACell, Inc. Announces Agreement to be Exclusive US Distributor of Xpansion Micro-Autografting Kit

  ACell will be the exclusive US distributor of ATT’s Xpansion micro-autografting kit, which offers a novel approach to split-thickness skin grafting procedures used to manage complex wounds.

  February 21, 2018

   · 

  2 min read
• Business

  Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results

  Blueprint Medicines Corporation, a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2017.

  February 21, 2018

   · 

  20 min read
• Biotech Bay

  PROCEPT BioRobotics Announces $118 Million Financing

  PROCEPT BioRobotics announced today that it raised $118 million to support the worldwide commercialization of the company’s Aquablation therapy for the minimally invasive treatment of benign prostatic hyperplasia.

  February 21, 2018

   · 

  3 min read
• BioMidwest

  Versiti among first in U.S. to offer pathogen reduced platelets

  Technology reduces risk for infections and makes blood transfusions safer for patients.

  February 21, 2018

   · 

  2 min read
• Business

  The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results

  The Medicines Company today reported its financial results for the fourth quarter and full year ended December 31, 2017.

  February 21, 2018

   · 

  16 min read